Chemotherapy of candidiasis: study of ABC transporter- mediated azole resistance and identification of a novel antifungal therapeutic strategy
Candida albicans is a major fungal pathogen that causes systemic bloodstream infections with high mortality rate in immune-compromised patients. Current treatment of candidiasis involves the use of azoles (the most widely used antifungal agents that target ergosterol biosynthesis) and echinocandins...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
McGill University
2011
|
| Subjects: | |
| Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103634 |